Yahoo Web Search

Search results

1. • Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and...

     WFRV 5 Green Bay· 4 days ago

     Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is offering consumers an opportunity to be featured in upcoming campaigns for their biggest brands, including BOTOX® Cosmetic, the

2. • 

     AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That

     Investor's Business Daily· 6 hours ago

     Botox as a cosmetic treatment brought in $633 million in sales and missed forecasts for $689...

3. • 

     AbbVie (ABBV) Q1 2024 Earnings Call Transcript

     Motley Fool via Yahoo Finance· 7 hours ago

     We also gained U.S. approval of Juvederm Voluma XC for temple hollows, further strengthening our leadership in aesthetic fillers, and we executed several...

4. • 

     AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges

     GuruFocus.com via Yahoo Finance· 13 hours ago

     However, the aesthetics portfolio experienced a downturn, with a 4.0% decrease in revenues to $1.249...

5. • 

     AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View

     Zacks via Yahoo Finance· 10 hours ago

     The company’s share of profit from U.S. sales was $12 million. AbbVie’s aesthetics portfolio sales...

6. • 

     AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth

     Market Watch· 15 hours ago

     AbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...

7. • 

     We Tested Nearly 1,000 New Beauty Products to Find the Ones Actually Worth Buying in 2024

     Good Housekeeping via Yahoo News· 4 days ago

     These are the 75 award-winning beauty products of 2024 chosen by Good Housekeeping experts. See why...

8. • AbbVie Reports First-Quarter 2024 Financial Results

     WPRI Providence· 15 hours ago

     ...Percent on a Reported Basis, or 2.5 Percent on an Operational Basis; Global Botox Cosmetic Net Revenues Were $633 Million; Global Juvederm Net Revenues Were $297 MillionSuccessfully Completed Acquisition of ImmunoGen and its Flagship Cancer Therapy, ElahereRaises 2024 Adjusted...

9. • 

     AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?

     Zacks via Yahoo Finance· 4 days ago

     In the aesthetics franchise, we expect overall sales to rise slightly as we expect a slight recovery...

10. • 

      The Ultimate Guide to Big Data Strategy

      TechBullion· 4 days ago

      The sheer volume, velocity, and variety of data – commonly referred to as ‘big data’ – present both unprecedented opportunities and unprecedented...